Clinical Trial Detail

NCT ID NCT04466891
Title A Study of ZW25 (Zanidatamab) in Subjects With Advanced or Metastatic HER2-Amplified Biliary Tract Cancers
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Zymeworks Inc.
Indications

biliary tract cancer

gallbladder cancer

intrahepatic cholangiocarcinoma

Therapies

ZW25

Age Groups: adult senior

Additional content available in CKB BOOST